"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Descriptor ID |
D007167
|
MeSH Number(s) |
E02.095.465.425
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1996 | 1 | 0 | 1 |
1998 | 0 | 3 | 3 |
1999 | 2 | 1 | 3 |
2000 | 3 | 2 | 5 |
2001 | 2 | 5 | 7 |
2002 | 2 | 3 | 5 |
2003 | 2 | 4 | 6 |
2004 | 5 | 8 | 13 |
2005 | 3 | 2 | 5 |
2006 | 4 | 2 | 6 |
2007 | 4 | 1 | 5 |
2008 | 7 | 6 | 13 |
2009 | 4 | 2 | 6 |
2010 | 7 | 5 | 12 |
2011 | 5 | 5 | 10 |
2012 | 8 | 7 | 15 |
2013 | 8 | 9 | 17 |
2014 | 8 | 8 | 16 |
2015 | 9 | 15 | 24 |
2016 | 20 | 2 | 22 |
2017 | 22 | 3 | 25 |
2018 | 29 | 14 | 43 |
2019 | 29 | 16 | 45 |
2020 | 19 | 25 | 44 |
2021 | 22 | 20 | 42 |
2022 | 2 | 28 | 30 |
2023 | 2 | 27 | 29 |
2024 | 2 | 5 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Plain Language Summary: Immunotherapy for Inhalant Allergy. Otolaryngol Head Neck Surg. 2024 Mar; 170(3):668-674.
-
Therapeutic synthetic and natural materials for immunoengineering. Chem Soc Rev. 2024 Feb 19; 53(4):1789-1822.
-
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS Nano. 2024 Feb 13; 18(6):5152-5166.
-
Immunoengineering a Future of Molecular, Material, and Cellular Therapeutics. J Immunol. 2024 01 15; 212(2):167-168.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. J Exp Clin Cancer Res. 2024 Jan 02; 43(1):6.
-
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jan 01; 10(1):32-41.
-
Melanoma and microbiota: Current understanding and future directions. Cancer Cell. 2024 Jan 08; 42(1):16-34.
-
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT). Lung Cancer. 2024 Jan; 187:107441.
-
Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms. Sci Rep. 2023 12 18; 13(1):22541.